SUPPLEMENT DELIVERY FORMS CAN BE AS IMPORTANT AS THE SUPPLEMENT ITSELF

Now that you have the perfect formula to add to your product line, what dosage form should you choose for delivery? Capsules, tablets, softgels, powder or liquid? During the development process for a new dietary supplement, besides the choice of active ingredients, it’s important to consider the final dosage form. The dosage form is not only important for how the product will ultimately be presented to the consumer but also may have critical influence on the formulation itself due to technical, efficacy and shelf life constraints.

Fortunately, there are a variety of dosage delivery options across supplements and plenty of new technologies and trends in the industry.

Powders and Liquids: Mixing it Up

Traditional forms such as tablets and capsules along with powders and liquids require different packaging and storage conditions to deliver safe and efficacious products while still appealing to shifting consumer trends. When deciding which supplements are best suited to an individual’s needs, in addition to overall product quality, it is essential to consider how delivery form may impact usability, stability and shelf life. Otherwise, you end up with products that harden, oxidize, taste bad, mix badly, change color, or even become rancid. Certain ingredients, for example, mix best in powder form. Protein or other nutrients that do not require exact measurements are especially well-suited to powder formulas. The downside is that powder sitting in water over time can cause microbial growth, making it dangerous to consume. Liquids are another option, especially for a quick, no-hassle way to take a supplement. However, liquid formulations limit the amount of active material available in a serving and are not ideal for bad-tasting substances. Popular dosage forms are diverse and expanding with consumer preference.

Tablets, Capsules, and Softgels: All in Good Taste

Capsules are perfect for almost any product needing a highly precise dosage measurement or for those with a bad taste. Tablets can also deliver a precisely measured dose and offer a similar breakdown time to capsules: about 20 minutes. However, it is possible to scientifically manipulate dissolution time by coating capsules in ingredients targeted to certain delivery specifications. Softgels offer an effective delivery form for liquid or oil-based formulas. Available in different sizes and colors, the contents are typically suspended in oils, making softgels and ideal delivery form for lipid- and fat-soluble nutrients such as efficacious oils, fatty acids, fat-soluble extracts or fat-soluble lettered vitamins. Innovative capsule-in-capsule technology makes it possible to combine both powders and liquids into a single dosage form, creating new opportunities to have incompatible ingredients play well together to deliver added benefits not previously possible.

Powders in Stick Packs: Easy-to-Swallow Innovations

Powders in stick packs, or sachets, are gaining popularity. These new technologies have been developed partly in response to issues of swallowability. Other dosage forms or delivery systems are seeing increasing interest to avoid the “pill fatigue” issue that seems to be trending. Powders in Stick Packs and liquids in “shots” seem to be gaining ground in the market due to their convenience and portability for today’s on-the-go lifestyle.

Important Considerations for Supplement Dosage Forms

Quality will always be a key consideration in choosing wellness supplements. However, efficacy and bioavailability are critical as well. Depending on the dosage form, one may have to rethink formulation requirements to accommodate the attributes needed. For example, flow and compaction characteristics, particle size and solubility all must fit the purpose for solid dosage forms. Add to those taste and appearance characteristics for those forms that will be consumed in powder or liquid forms and formulation issues can become much more complicated. Shelf life requirements are also a major consideration that should not be overlooked in the choice of ingredients, dosage form and packaging format. After all, the best ingredients in the best dosage form hold little value to the consumer if they do not deliver the best quality and efficacy at the stated expiration date on the label.

As a start-to-finish provider, Deerland Probiotics & Enzymes delivers contract manufacturing services for science-backed enzyme and probiotic-based formulations. Learn more here about the manufacturing capabilities of Deerland Probiotics & Enzymes.

Follow us on social media for the latest updates in B2B!

Image

Latest

GPU infrastructure
Amberd Moves to the Front of the Line With QumulusAI’s GPU Infrastructure
February 18, 2026

Reliable GPU infrastructure determines how quickly AI companies can execute. Teams developing private LLM platforms depend on consistent high-performance compute. Shared cloud environments often create delays when demand exceeds available capacity Mazda Marvasti, CEO of Amberd, says waiting for GPU capacity did not align with his company’s pace. Amberd required guaranteed availability to support…

Read More
private LLM
QumulusAI Secures Priority GPU Infrastructure Amid AWS Capacity Constraints on Private LLM Development
February 18, 2026

Developing a private large language model(LLM) on AWS can expose infrastructure constraints, particularly around GPU access. For smaller companies, securing consistent access to high-performance computing often proves difficult when competing with larger cloud customers. Mazda Marvasti, CEO of Amberd AI,  encountered these challenges while scaling his company’s AI platform. Because Amberd operates its own…

Read More
custom AI chips
Custom AI Chips Signal Segmentation for AI Teams, While NVIDIA Sets the Performance Ceiling for Cutting-Edge AI
February 18, 2026

Microsoft’s introduction of the Maia 200 adds to a growing list of hyperscaler-developed processors, alongside offerings from AWS and Google. These custom AI chips are largely designed to improve inference efficiency and optimize internal cost structures, though some platforms also support large-scale training. Google’s offering is currently the most mature, with a longer production…

Read More
GPUs
OpenAI–Cerebras Deal Signals Selective Inference Optimization, Not Replacement of GPUs
February 18, 2026

OpenAI’s partnership with Cerebras has raised questions about the future of GPUs in inference workloads. Cerebras uses a wafer-scale architecture that places an entire cluster onto a single silicon chip. This design reduces communication overhead and is built to improve latency and throughput for large-scale inference. Mark Jackson, Senior Product Manager at QumulusAI, says…

Read More